Free Cancer Report

Book Appointment with Dr Avani Jain in Vadodara

Dr Avani Jain

Nuclear Radiologist

6 Years Exp. Vadodara

Breast Cancer

HCG Cancer Centre, Vadodara

6 years of experience

DNB (Nuclear Medicine), Dip CBNC(USA), FEBNM, FANMB


About Dr Avani Jain:

Dr. Avani completed her DNB in Nuclear Medicine from a renowned institute in Chennai She is a certified Nuclear Cardiologist and fellow of European Board & Asian Board of Nuclear Medicine She is an experienced Nuclear Medicine physician with rich and diverse experience in the field of molecular imaging (PET-CT), Nuclear Medicine and Radionuclide Therapy Expertise in Multimodality imaging skills (PET-CT, SPET-CT, Gamma camera), and Targeted radionuclide therapy Her special interest lies in Onco-Imaging, Novel radiotracers in PET-CT, Cardiac PET-CT, Neurodegenerative disorders She has numerous publications and scientific paper presentations in various national and international journals to her credit


DNB (Nuclear Medicine), Dip CBNC(USA), FEBNM, FANMB


Consultant & Head - HCG Cancer Center, Vadodara Full-time Junior Consultant, Nuclear Medicine at Apollo Main Hospital,Chennai Registrar, Nuclear Medicine & PET-CT at Apollo Main Hospital, Chennai

Areas of interest:

Breast Cancer, Mouth Cancer.

Research publications:

F-18 FDG PET-CT in pyrexia of unknown origin in adult solid organ transplant recipients Pericardial synovial sarcoma followed up with contrast enhanced PET-CT Evolving role of contrast enhanced F-18 FDG PET-CT in pyrexia of unknown origin in solid organ transplant recipients Diagnostic importance of contrast enhanced 18 F-fluorodeoxyglucose positron emission computed tomography in patients with tumor induced osteomalacia: Our experience Standardisation of "_In-House fatty meal" methodology for cholescintigraphy. '_In-House Fatty Meal' cholescintigraphy in characterisation of dyspepsia symptom complex. Assessing the early use of 18f-fluorodeoxyglucose PET-CT in the diagnostic pathway of patients with metastatic malignant disease of unknown primary origin Contrast-enhanced [18F] fluoro-deoxyglucose positron emission tomography-computed tomography as an initial imaging modality in patients with metastatic malignancy of undefined primary origin. 18F-fluoro-deoxyglucose positron emission tomography-computed tomography in initial assessment and diagnosis of right atrial angiosarcoma with widespread visceral metastases: A rare case report and review of the literature. ТDiagnostic importance of contrast enhanced 18F- fluorodeoxyglucose positron emission computed tomography (FDG PET-ceCT) in patients with tumor induced phosphaturic osteomalacia Р Our experience. Ventilation-perfusion scintigraphy in ФEmergency Radiology & Imaging', Monoarticular carcinomatous knee joint arthritis as an initial presentation of cervical carcinoma 18F-FDG PET-CT as an initial imaging modality for evaluation of patients with metastasis of unknown site of primary malignancy ТDiagnostic utility of 18F-FDG PET-CT in carcinoma of unknown primaryУ


Breast Cancer, Mouth Cancer.